Barnes v. United States

516 F. Supp. 1376, 1981 U.S. Dist. LEXIS 9656
CourtDistrict Court, W.D. Pennsylvania
DecidedJune 29, 1981
DocketCiv. A. 80-425
StatusPublished
Cited by10 cases

This text of 516 F. Supp. 1376 (Barnes v. United States) is published on Counsel Stack Legal Research, covering District Court, W.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Barnes v. United States, 516 F. Supp. 1376, 1981 U.S. Dist. LEXIS 9656 (W.D. Pa. 1981).

Opinion

FINDINGS OF FACT AND CONCLUSIONS OF LAW

COHILL, District Judge.

I.

Background

Plaintiff, Sandra K. Barnes, suffered Guillain-Barre Syndrome as a result of a shot she received during the 1976 United *1378 States swine flu inoculation program. She is permanently crippled and confined to a wheelchair.

The defendant, the United States of America, has admitted liability for her injuries. The only issues to be determined in this non-jury case relate to the damages to be awarded.

Robert E. Barnes, Mrs. Barnes’ husband, seeks damages for loss of consortium.

The case was brought before the Court pursuant to the National Swine Flu Immunization Program of 1976, 42 U.S.C. § 247b (1976), the Federal Tort Claims Act, 28 U.S.C. § 2671 et seq. (1976), and 28 U.S.C. § 1346(b) (1976).

Pursuant to Fed.R.Civ.P. 52, we make the following Findings of Fact and Conclusions of Law.

II.

Findings of Fact

A. Overview

In this case the defendant has conceded that Mrs. Barnes suffered from GuillainBarre Syndrome caused by receiving a swine flu shot and has admitted liability.

The National Swine Flu Immunization Program of 1976, 42 U.S.C. § 247b (1976), was an attempt by the Federal Government to inoculate the entire adult population of the United States against the threat of a swine flu epidemic. It was the largest immunization program in this country’s history, and over forty-five million Americans— or one-third of the adult population — were vaccinated. The initial vaccinations occurred on October 1, 1976; the program was suspended on December 16, 1976. 1 The program, for which $135 million was initially appropriated by Congress, called for using both private and public health care systerns to achieve its goal of inoculating the entire adult population by the end of November, 1976. The November deadline was critical since the season of intense flu transmission in the United States is generally considered to be September through March. See The Swine Flu Program: An Unprecedented Venture in Preventive Medicine, Report to Congress by the Comptroller General of the United States, June 27, 1977.

The Swine Flu Act became law on August 12, 1976 and was applicable to all swine flu inoculations administered after September 30, 1976. Important provisions of the Act include the following:

1. The Act creates a cause of action against the United States for any personal injury or wrongful death sustained as a result of the swine flu inoculation, 42 U.S.C. § 247b(k)(2)(A);
2. it makes that cause of action the exclusive' remedy, 42 U.S.C. § 247b(k)(3), and it abolishes any cause of action against the vaccine manufacturer; and
3. it makes the procedures of the Federal Tort Claims Act applicable to suits brought pursuant to the Swine Flu Act, 42 U.S.C. § 247b(k).

The program was prompted in part by the medical discovery in early February, 1976 at Fort Dix, New Jersey, of military personnel having a new strain of influenza virus antigenically related to the virus prevalent during the 1918-19 swine flu pandemic. That pandemic was responsible for twenty million deaths worldwide, including 400,000 in the United States alone. 2 Prior to 1930, the 1918-19 strain was the predominate cause of influenza in the United States. Since 1930, the virus had been limited to transmission among swine only with occasional *1379 transmission from swine to human and no secondary person-to-person transmission. 3

In addition, the Swine Flu Act was occasioned by the collapse of the commercial liability insurance market, both for vaccine manufacturers and other program participants. 4 The cases of Davis v. Wyeth Laboratories, Inc., 399 F.2d 121 (9th Cir. 1968), and Reyes v. Wyeth Laboratories, 498 F.2d 1264.(5th Cir.), cert. denied, 419 U.S. 1096, 95 S.Ct. 687, 42 L.Ed.2d 688 (1974), which held a manufacturer of polio vaccine strictly liable in tort, grevtly contributed to the insurance problem. For this reason, the Swine Flu Act provided that the exclusive remedy for injury caused by the vaccine would be against the United States. However, since the manufacturers could still insure themselves against negligence liability, they may be liable in a suit by the United States if the United States is found liable on a negligence theory. 42 U.S.C. § 247b(k)(7).

History has demonstrated that no swine flu epidemic occurred during the winter of 1976 — 77. As can be expected, many people who were inoculated also incurred some type of illness, injury or adverse medical condition in a period relative to the vaccination. Lawsuits such as the instant one, were filed throughout the country for illnesses allegedly resulting from the immunization. In addition, numerous administrative claims have been filed. The critical question presented in these cases is the causal relationship between the immunization from the claimed illness. However, mere temporal relation between the onset of a disease and the vaccination is insufficient to establish legal causation. In the case of Guillain-Barre Syndrome, the government has stipulated that the swine flu vaccine can cause Guillain-Barre Syndrome in some instances, and it has so conceded here.

Guillain-Barre Syndrome is a neurologic disorder, inflammatory in nature, which affects the peripheral, as opposed to the central, nervous system. The syndrome characterizes a set of neurologic symptoms rather than defining a specific organic disorder. The disease was first described in 1859 by Dr. O. Landry, and referred to as “Landry’s Paralysis.” 5 It was again described in 1916 by Drs. Guillain, Barre and Stohl.

Related

Leverence v. United States Fidelity & Guaranty
462 N.W.2d 218 (Court of Appeals of Wisconsin, 1990)
Reilly v. United States
665 F. Supp. 976 (D. Rhode Island, 1987)
Burns v. Pepsi-Cola Metropolitan Bottling Co.
510 A.2d 810 (Supreme Court of Pennsylvania, 1986)
District of Columbia v. Jackson
451 A.2d 867 (District of Columbia Court of Appeals, 1982)
Tabaczynski v. United States
529 F. Supp. 156 (E.D. Michigan, 1981)

Cite This Page — Counsel Stack

Bluebook (online)
516 F. Supp. 1376, 1981 U.S. Dist. LEXIS 9656, Counsel Stack Legal Research, https://law.counselstack.com/opinion/barnes-v-united-states-pawd-1981.